deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03039699

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children

International Multicenter, Double-blind, Randomized, Parallel Group Placebo-Controlled Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children

Sponsor: Materia Medica Holding

Conditions Viral Intestinal Infection
Interventions Ergoferon Placebo
Updated 16 times since 2017 Last updated: Sep 23, 2020 Started: Jun 23, 2016 Primary completion: Jun 1, 2019 Completion: Jun 1, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Viral Intestinal Infection and is currently completed. Materia Medica Holding leads this study, which shows 16 recorded versions since 2016 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~Aug 2017 · 4 months · monthly snapshot~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Nov 2018 · 3 months · monthly snapshot~Nov 2018 – ~Feb 2019 · 3 months · monthly snapshot~Feb 2019 – ~Jun 2019 · 4 months · monthly snapshot~Jun 2019 – ~Sep 2019 · 3 months · monthly snapshot~Sep 2019 – ~Dec 2019 · 3 months · monthly snapshot~Dec 2019 – ~Mar 2020 · 3 months · monthly snapshot~Mar 2020 – ~Nov 2020 · 8 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 11 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Nov 2020 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 11 earlier versions

  1. Mar 2020 — Nov 2020 [monthly]

    Completed PHASE4

  2. Dec 2019 — Mar 2020 [monthly]

    Completed PHASE4

  3. Sep 2019 — Dec 2019 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  4. Jun 2019 — Sep 2019 [monthly]

    Recruiting PHASE4

  5. Feb 2019 — Jun 2019 [monthly]

    Recruiting PHASE4

  6. Nov 2018 — Feb 2019 [monthly]

    Recruiting PHASE4

  7. Aug 2018 — Nov 2018 [monthly]

    Recruiting PHASE4

  8. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE4

  9. Aug 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

  10. Apr 2017 — Aug 2017 [monthly]

    Recruiting PHASE4

    Status: Enrolling By Invitation → Recruiting

  11. Feb 2017 — Apr 2017 [monthly]

    Enrolling By Invitation PHASE4

    First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Materia Medica Holding
Data source: Materia Medica Holding

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations